S1. CLOZAPINE RECHALLENGE FOLLOWING NEUTROPENIA USING GRANULOCYTE COLONY-STIMULATING FACTOR: A QUEBEC CASE SERIES

BACKGROUND: Clozapine possesses unique efficacy profile in treatment-resistant schizophrenia but is associated with neutropenia and agranulocytosis, in respectively, 3% and 0.7% of exposed patients. Granulocyte colony-stimulating factor (G-CSF) has been used to allow clozapine continuation or rechal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Schizophr Bull
Autors principals: Béchard, Laurent, Corbeil, Olivier, Plante, Maude, Thivierge, Marc-André, Lafrenière, Charles-Émile, Roy, Marc-André, Demers, Marie-France
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Poster Session I
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7234194/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbaa031.067
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars